Alector (ALEC) Change in Accured Expenses (2018 - 2026)
Alector's (ALEC) quarterly Change in Accured Expenses came in at -$11.0 million in Q1 2026, up 13.35% year-on-year from -$9.7 million in Q1 2025, and down 1112.21% on a QoQ basis from $1.1 million in Q4 2025.
Alector (ALEC) Change in Accured Expenses (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Change in Accured Expenses data on file, last reported at -$11.0 million in Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 13.35% year-over-year to -$11.0 million in Q1 2026; TTM through Mar 2026 was -$11.2 million, a 439.22% decrease from a year earlier, with the FY2025 full-year figure at -$12.9 million, down 3895.29% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$11.0 million, down from $1.1 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for ALEC reached as high as $8.0 million in Q3 2023 and fell as low as -$12.7 million in Q1 2025.
- Historically, Change in Accured Expenses has averaged -$1.4 million across 5 years, with a median of -$1.1 million in 2022.
- Across the five-year window, Change in Accured Expenses soared 823.83% in 2023 and tumbled 900.21% in 2025, its largest moves.
- Year by year, Change in Accured Expenses stood at $4.6 million in 2022, then tumbled by 145.79% to -$2.1 million in 2023, then surged by 420.84% to $6.8 million in 2024, then tumbled by 84.0% to $1.1 million in 2025, then slumped by 1112.21% to -$11.0 million in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were -$11.0 million in Q1 2026, $1.1 million in Q4 2025, and $2.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -16.82 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -16.74 Mn |
| 10 | Alector | 164.78 Mn | -41.74 Mn | - | -11.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.02 Mn |
| Mar 31, 2026 | -11.02 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Jun 30, 2025 | -3.79 Mn |
| Jun 30, 2025 | -3.79 Mn |
| Mar 31, 2025 | -12.72 Mn |
| Mar 31, 2025 | -12.72 Mn |
| Dec 31, 2024 | 6.81 Mn |
| Dec 31, 2024 | 6.81 Mn |
| Sep 30, 2024 | 3.37 Mn |
| Sep 30, 2024 | 3.37 Mn |
| Jun 30, 2024 | 473,000.00 |
| Jun 30, 2024 | 473,000.00 |
| Mar 31, 2024 | -10.30 Mn |
| Mar 31, 2024 | -10.30 Mn |
| Dec 31, 2023 | -2.12 Mn |
| Dec 31, 2023 | -2.12 Mn |